First class Masters Degree in Bioinformatics / Biotechnology / Computational Biology / or related areas or Bachelors Degree in Engineering or Technology or Medicine with specialization in Bioinformatics / Biotechnology
M.Sc. / M.Tech. in Life Sciences / Biotechnology / Agricultural Biotechnology, Any national level examination or eligibility test such as CSIR-UGC, NET, GATE, DBT.
Johnson & Johnson has announced encouraging results from its pivotal Phase 2/3 ENERGY study evaluating IMAAVY (nipocalimab-aahu) in patients with warm autoimmune hemolytic anemia (wAIHA), a rare autoimmune blood disorder that currently has no FDA-approved therapies. The findings suggest that the investigational treatment could offer a much-needed targeted option for patients struggling with chronic anemia and severe fatigue.
Danish pharmaceutical giant Novo Nordisk has disclosed an IT security incident that resulted in unauthorized access to a limited number of its internal systems, including data related to some clinical trial participants. The company stated that certain non-public information was copied externally without authorization and that an investigation is currently underway.
Postgraduate degree in life sciences, pharmacy, biotechnology, clinical research, regulatory affairs or other relevant discipline from a recognized university, with at least 5 years of relevant experience in project or program management
M.Sc. in Forensic Science (with specialization/ dissertation work/ course work/ project work in the field of Chemical Sciences). OR At least 2nd class M.Sc. in Chemistry/ Bio-Chemistry, Pharmacy/ M.S.(Pharm.)/ M. Pharm. from a recognized University.